Copyright: ©Author(s) 2026.
World J Clin Pediatr. Sep 9, 2026; 15(3): 120927
Published online Sep 9, 2026. doi: 10.5409/wjcp.120927
Published online Sep 9, 2026. doi: 10.5409/wjcp.120927
Table 2 Cholesterol, triglycerides and high-density lipoproteins levels at different time points after asparaginase treatment of patient 2
| Patient 2 | Reference interval | Before PEG-ASP therapy | PEG-ASP therapy | |||
| Day 12 | Day 14 | Day 21 | Day 31 | |||
| CHOL (mmol/L) | 3.10-5.20 | NA | 13.39 | 3.97 | 4.87 | 4.99 |
| TG (mmol/L) | 0.00-1.69 | NA | 30.91 | 2.50 | 4.38 | 2.25 |
| HDL (mmol/L) | 1.17-1.55 | NA | 1.17 | 0.49 | 0.79 | 1.32 |
- Citation: Krivosheina M, Bakaleiko V, Toshina Y, Baratashvili G, Sokolnikova P, Kalinina OV, Alieva A, Dinikina Y, Kostareva AA. Genetic predisposition of Asparaginase-induced hypertriglyceridemia in children with acute lymphoblastic leukemia: Two case reports and review of literature. World J Clin Pediatr 2026; 15(3): 120927
- URL: https://www.wjgnet.com/2219-2808/full/v15/i3/120927.htm
- DOI: https://dx.doi.org/10.5409/wjcp.120927